Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
- PMID: 30360733
- DOI: 10.2174/1389450119666181022153016
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
Abstract
Molecular docking is a process through which small molecules are docked into the macromolecular structures for scoring its complementary values at the binding sites. It is a vibrant research area with dynamic utility in structure-based drug-designing, lead optimization, biochemical pathway and for drug designing being the most attractive tools. Two pillars for a successful docking experiment are correct pose and affinity prediction. Each program has its own advantages and drawbacks with respect to their docking accuracy, ranking accuracy and time consumption so a general conclusion cannot be drawn. Moreover, users don't always consider sufficient diversity in their test sets which results in certain programs to outperform others. In this review, the prime focus has been laid on the challenges of docking and troubleshooters in existing programs, underlying algorithmic background of docking, preferences regarding the use of docking programs for best results illustrated with examples, comparison of performance for existing tools and algorithms, state of art in docking, recent trends of diseases and current drug industries, evidence from clinical trials and post-marketing surveillance are discussed. These aspects of the molecular drug designing paradigm are quite controversial and challenging and this review would be an asset to the bioinformatics and drug designing communities.
Keywords: Molecular docking; algorithms; drug designing; molecular dynamics; pharmacophore; scoring functions..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.J Chem Inf Model. 2014 Oct 27;54(10):2697-717. doi: 10.1021/ci5003735. Epub 2014 Sep 30. J Chem Inf Model. 2014. PMID: 25266271
-
Methods for docking small molecules to macromolecules: a user's perspective. 2. Applications.Curr Pharm Des. 2014;20(20):3360-72. doi: 10.2174/13816128113199990606. Curr Pharm Des. 2014. PMID: 23947644 Review.
-
Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors.Molecules. 2015 Jun 23;20(6):11569-603. doi: 10.3390/molecules200611569. Molecules. 2015. PMID: 26111183 Free PMC article. Review.
-
Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.Cell Chem Biol. 2018 Nov 15;25(11):1318-1325. doi: 10.1016/j.chembiol.2018.07.006. Epub 2018 Aug 9. Cell Chem Biol. 2018. PMID: 30100349 Free PMC article. Review.
-
Docking and Virtual Screening in Drug Discovery.Methods Mol Biol. 2017;1647:255-266. doi: 10.1007/978-1-4939-7201-2_18. Methods Mol Biol. 2017. PMID: 28809009
Cited by
-
Qingfei Huoxue Decoction and Its Active Component Narirutin Alleviate LPS-Induced Acute Lung Injury by Regulating TLR4/NF-κB Pathway Mediated Inflammation.J Inflamm Res. 2024 Oct 21;17:7503-7520. doi: 10.2147/JIR.S480101. eCollection 2024. J Inflamm Res. 2024. PMID: 39464340 Free PMC article.
-
Integrating network pharmacology, molecular docking and non-targeted serum metabolomics to illustrate pharmacodynamic ingredients and pharmacologic mechanism of Haizao Yuhu Decoction in treating hyperthyroidism.Front Endocrinol (Lausanne). 2024 Sep 25;15:1438821. doi: 10.3389/fendo.2024.1438821. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39387049 Free PMC article.
-
Computational Drug Design Strategies for Fighting the COVID-19 Pandemic.Adv Exp Med Biol. 2024;1457:199-214. doi: 10.1007/978-3-031-61939-7_11. Adv Exp Med Biol. 2024. PMID: 39283428
-
Network pharmacology and molecular docking to explore the treatment potential and molecular mechanism of Si-Miao decoction against gouty arthritis.Medicine (Baltimore). 2024 May 31;103(22):e38221. doi: 10.1097/MD.0000000000038221. Medicine (Baltimore). 2024. PMID: 39259129 Free PMC article.
-
In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase.Pharmaceuticals (Basel). 2024 Aug 21;17(8):1093. doi: 10.3390/ph17081093. Pharmaceuticals (Basel). 2024. PMID: 39204198 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources